GlassScriptPhysician profile
Peter Anthony Mennie
NPI 1972765329
$8,476.52
in general payments reported to CMS, 2019-2025
40 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $654 · 2021: $1,134 · 2022: $1,221 · 2023: $1,687 · 2024: $1,924 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,160 · Honoraria: $500 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,159.87 |
| Honoraria | $500.00 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,278.97 | 2019-2025 | Erleada, Akeega, Balversa |
| 180 Medical, INC. | $1,089.12 | 2019-2025 | Gentlecath, Gentlecath Glide |
| Astellas Pharma US INC | $973.83 | 2019-2024 | Myrbetriq, Veozah |
| Boston Scientific Corporation | $812.56 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml, Ams 800 Artificial Urinary Sphincter |
| Verity Pharmaceuticals INC. | $762.46 | 2021-2025 | Trelstar, Tlando |
| Pfizer INC. | $409.00 | 2019-2025 | |
| Coloplast Corp | $303.49 | 2019-2023 | Titan |
| Endo Pharmaceuticals INC. | $292.19 | 2019-2024 | Xiaflex, Aveed |
| Convatec INC. | $284.16 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $269.71 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $240.08 | 2019-2022 | |
| Endo USA, INC. | $207.31 | 2024-2025 | Xiaflex |
| Hollister Incorporated | $163.20 | 2021-2023 | Vapro Pocket |
| Astrazeneca Pharmaceuticals LP | $116.76 | 2020 | |
| Axonics, INC. | $112.97 | 2022-2024 | Axonics |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Mennie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.